Oramed To Begin Advanced Trials On ‘Insulin Pill’

May 31, 2015 | Oramed Pharmaceuticals, an Israeli company developing an insulin pill for diabetics, announced this week that it submitted a study protocol for its Phase IIb trials with the US Food & Drug Administration (FDA). The drug, tentatively named ORMD-0801 is an orally ingestible insulin capsule for the control and treatment of diabetes. It’s expected that the pill will change the face of current diabetes treatments. Oramed was founded in 2006 and is headquartered in Jerusalem.